PLAGL1 抗体 (N-Term)
-
- 抗原 See all PLAGL1 抗体
- PLAGL1 (Pleiomorphic Adenoma Gene-Like 1 (PLAGL1))
-
抗原表位
- N-Term
-
适用
- 人, 小鼠, 大鼠, 犬, Cow, Pig
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This PLAGL1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 交叉反应
- 大鼠, 小鼠, 牛, 猪, 犬
- 纯化方法
- Purified
- 免疫原
- PLAGL1 antibody was raised in rabbit using the N terminal of PLAGL1 as the immunogen
- Top Product
- Discover our top product PLAGL1 Primary Antibody
-
-
- 应用备注
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - 说明
-
PLAGL1 Blocking Peptide, catalog no. 33R-3009, is also available for use as a blocking control in assays to test for specificity of this PLAGL1 antibody
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 浓度
- Lot specific
- 缓冲液
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- 注意事项
- Avoid repeated freeze/thaw cycles.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- 抗原
- PLAGL1 (Pleiomorphic Adenoma Gene-Like 1 (PLAGL1))
- 别名
- PLAGL1 (PLAGL1 产品)
- 别名
- PLAGL1 antibody, LOT1 antibody, ZAC antibody, ZAC1 antibody, Lot1 antibody, Zac1 antibody, PLAG1 like zinc finger 1 antibody, uncharacterized LOC100350914 antibody, pleiomorphic adenoma gene-like 1 antibody, PLAGL1 antibody, LOC100350914 antibody, Plagl1 antibody
- 背景
- PLAGL1 is a C2H2 zinc finger protein with transactivation and DNA-binding activity. This gene has been shown to exhibit antiproliferative activities and is a tumor suppressor gene candidate.This gene encodes a C2H2 zinc finger protein with transactivation and DNA-binding activity. This gene has been shown to exhibit antiproliferative activities and is a tumor suppressor gene candidate. Two transcript variants encoding different isoforms have been found for this gene. Synonyms: Polyclonal PLAGL1 antibody, Anti-PLAGL1 antibody, pleiomorphic adenoma gene-like 1 antibody, DKFZp781P1017 antibody, LOT1 antibody, MGC126275 antibody, MGC126276 antibody, ZAC antibody, ZAC1 antibody.
-